🟠 Moderate Evidence
A biochemical pathway that goes unmonitored in clinical practice may be quietly sabotaging heart function in millions of patients. Loop diuretics—the standard treatment for heart failure—deplete thiamine (vitamin B1), the essential cofactor for pyruvate dehydrogenase, the enzyme that converts all carbohydrate-derived calories into cellular energy. Research by Hänninen et al. found that 33% of hospitalized heart failure patients were thiamine deficient, compared with 12% in control groups, raising questions about whether routine thiamine monitoring and supplementation should be standard practice for patients on chronic diuretic therapy.
Key takeaways
- Thiamine deficiency is present in 33% of heart failure patients versus 12% of controls, according to Hänninen et al. research
- Loop diuretics increase renal thiamine clearance; thiamine stores (25–30 mg total body) can be depleted in as little as 2–3 weeks without daily replenishment
- Without thiamine, pyruvate cannot be converted to acetyl-CoA and enters the citric acid cycle; instead it shunts to lactate, reducing ATP production and impairing cardiac energy metabolism
- Thiamine status is not routinely measured in standard blood panels, meaning deficiency often goes undetected despite measurable metabolic consequences
Thiamine Deficiency Prevalence in Heart Failure vs. Control Populations
Data from Hänninen et al. study of hospitalized patients
Source: Hänninen et al. | Georgian Medical Journal News
The Biochemistry: Why Thiamine Matters for Energy Production
Every calorie derived from carbohydrates must pass through pyruvate dehydrogenase (PDH) to generate ATP, the cell’s energy currency. Glycolysis—the initial breakdown of glucose into pyruvate—occurs in the cytoplasm and does not require thiamine. However, pyruvate cannot cross the mitochondrial membrane as acetyl-CoA without PDH catalyzing the conversion, and PDH cannot function without thiamine pyrophosphate (TPP) in its active site.
When thiamine is absent, pyruvate accumulates and is shunted to lactate instead. The citric acid cycle is starved of its primary fuel. ATP production drops. Lactate accumulates in the bloodstream, creating metabolic acidosis. For a failing heart—already struggling to generate sufficient contractile force—this metabolic block has immediate functional consequences.
The Clinical Reality: Diuretics and Depletion
The biochemical logic translates directly into measurable clinical pathology. In a study of hospitalized heart failure patients, Hänninen et al. measured thiamine status in 100 heart failure patients and 50 controls, finding that 33% of heart failure patients were thiamine deficient compared with 12% of controls. Loop diuretics—furosemide, torsemide, and bumetanide—are nearly universal in heart failure treatment. They work by blocking sodium reabsorption in the thick ascending limb of the loop of Henle, but they also increase renal clearance of thiamine.
Thiamine is water-soluble with total body stores of only 25–30 mg. Unlike fat-soluble vitamins, the body cannot build reserves. Without daily dietary replenishment, thiamine stores can be completely depleted in as little as 2–3 weeks. Most diuretic-treated heart failure patients receive no thiamine supplementation, leaving them vulnerable to progressive depletion.
Thirty-three percent of hospitalized heart failure patients are thiamine deficient—a rate 2.75 times higher than in control groups—yet thiamine status is not part of standard clinical blood panels.
— Hänninen et al., based on prospective observational research in hospitalized populations
A Vicious Metabolic Cycle
The diuretic-induced depletion creates a plausible cascade. A patient is started on furosemide for volume overload in heart failure. Furosemide increases urinary thiamine loss. Thiamine deficiency impairs PDH function, reducing cardiac ATP production and worsening contractility. As heart function deteriorates, the clinical team increases the diuretic dose to manage volume. More thiamine is lost. Myocardial energy metabolism worsens further. The cycle perpetuates.
Supplementation trials have shown mixed results on ejection fraction, but the metabolic logic is sound and the biochemical deficiency is measurable. If thiamine depletion contributes even partially to treatment-refractory heart failure, the opportunity cost of non-screening is substantial.
Beyond Heart Failure: Broader Populations at Risk
Thiamine deficiency extends well beyond heart failure. Diabetes is independently associated with low thiamine status, likely because carbohydrate metabolism—the pathway most dependent on thiamine—is dysregulated in glycemic disease. Chronic alcohol consumption impairs thiamine absorption in the gastrointestinal tract and increases urinary excretion. Bariatric surgery reduces the absorptive surface area available for thiamine uptake. Even high carbohydrate intake increases thiamine demand because carbohydrate oxidation is the metabolic pathway most heavily dependent on TPP.
Critically, thiamine status is not part of routine blood chemistry panels in most healthcare systems. Patients on loop diuretics, insulin, or with alcohol use disorder may be profoundly deficient without clinical awareness. The metabolism of each macronutrient follows distinct biochemical pathways, and thiamine is indispensable for the carbohydrate pathway specifically.
What this means
Frequently asked questions
How is thiamine deficiency diagnosed?
Thiamine status is measured via serum thiamine levels or—more specifically—thiamine pyrophosphate (TPP), the active cofactor form. Plasma thiamine is quick but less sensitive. Thiamine pyrophosphate effect (TPPE), measuring the enzyme transketolase before and after TPP addition, is more functional but requires specialized laboratories. Standard blood chemistry does not include thiamine.
Can you get thiamine from food?
Yes. Thiamine is abundant in pork, fish, whole grains, legumes, nuts, and seeds. However, water-soluble vitamins are not stored long-term, and diuretic-induced urinary losses may exceed typical dietary intake (1.1–1.2 mg/day in adults). This is why supplementation—not diet alone—is often necessary in diuretic-treated patients.
What dose of thiamine is safe to supplement?
Thiamine has no established upper limit of toxicity because it is water-soluble. Oral supplementation typically ranges from 25 mg to 100 mg daily for maintenance or repletion. Some cardiologists use 100–200 mg daily in heart failure patients on diuretics. Intravenous thiamine (100 mg daily for 3–5 days) is used for acute depletion, particularly in alcohol withdrawal settings. Supplementation should be discussed with your healthcare provider.
The challenge facing heart failure management is that thiamine depletion is both biochemically plausible and clinically measurable yet remains systematically invisible in routine practice. As loop diuretics remain the standard first-line treatment for volume overload, the opportunity to optimize cardiac energy metabolism through simple, inexpensive monitoring and supplementation continues to be missed. Future guidelines should consider whether thiamine status ought to be routine in diuretic-treated populations, particularly those with ejection fractions refractory to other interventions.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
